Silvant Capital Management »

Viking Therapeutics shares owned by Silvant Capital Management

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Silvant Capital Management from 13F filings

Historical chart of Silvant Capital Management investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Silvant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Silvant Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 17k 82.00

More positions owned by Silvant Capital Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Fair Isaac Corporation (FICO)
UnitedHealth (UNH)
Royal Caribbean Cruises (RCL)
Dex (DXCM)
salesforce (CRM)
Edwards Lifesciences (EW)

View all positions for Silvant Capital Management

Top funds holding Viking Therapeutics

FMR
BlackRock
Vanguard Group
Susquehanna International
Alliancebernstein
Citadel Advisors
Geode Capital Management
Pictet Asset Management Holding SA
Viking Global Investors
Caption Management
Ing Investment Management
Jpmorgan Chase & Co
Morgan Stanley
Perceptive Advisors
Perpetual

View all funds holding Viking Therapeutics